Baricitinib, Placebo and Antiviral Therapy for the Treatment of Patients With Moderate and Severe COVID-19
Clinical trial NCT04373044 · TERMINATED
Trial details
- NCT number
- NCT04373044
- Sponsor
- University of Southern California
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-01
- Primary completion
- 2021-05-12
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.